Melanin Nanoparticle MRI Contrast Agent with PEG Surface Modification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional MRI contrast agents, such as Gd-based agents, suffer from toxicity, short retention time in vivo, and poor water dispersibility, limiting their effectiveness and safety for imaging applications.
Innovation Solution
Development of melanin nanoparticles with controlled size and shape, coordinated with paramagnetic metal ions and surface-modified with PEGs for improved water dispersibility and prolonged retention, enhancing their use as a safe and effective MRI contrast agent.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional Gd-based contrast agents are used, then T1 contrast enhancement is achieved, but toxicity increases and retention time in vivo decreases
Solution Approach 1:
The patent combines melanin nanoparticles with paramagnetic metal ions (Gd3+, Mn2+, or Fe3+) to create a composite contrast agent. The melanin nanoparticle serves as a biocompatible carrier that provides both safety and extended retention time, while the paramagnetic ions provide the necessary contrast enhancement. This composite structure resolves the contradiction by integrating the benefits of both materials.
Solution Approach 2:
The melanin nanoparticle acts as an intermediary carrier that transports the paramagnetic metal ions throughout the body. This intermediary structure protects the toxic metal ions while extending their circulation time, allowing the contrast agent to maintain both safety and prolonged retention in vivo.
2Quantity of substance
If melanin is obtained from natural sources, then melanin is obtained, but purity decreases due to contamination with proteins and other biological materials
Solution Approach 1:
The patent extracts and isolates melanin from natural sources (cuttlefish ink, squid ink, or plant materials) through purification processes that remove contaminating proteins and other biological materials. This extraction process obtains sufficient melanin while achieving the required purity for biomedical applications.
Solution Approach 2:
The patent produces melanin with different properties depending on the source material and purification method used. Melanin from cuttlefish ink has different characteristics than plant-derived melanin, allowing optimization of local qualities for specific applications while maintaining high purity.
3Ease of manufacture
If conventional synthetic melanin is used, then melanin is produced, but water dispersibility decreases leading to precipitation and aggregation
Solution Approach 1:
The patent modifies the surface properties of synthetic melanin nanoparticles by controlling particle size (30-200 nm) and surface charge during synthesis. These parameter changes enhance water dispersibility and prevent aggregation, while maintaining the ease of chemical synthesis.
Solution Approach 2:
The patent divides melanin into nanoparticle-sized segments (30-200 nm) rather than using bulk melanin. This segmentation dramatically improves water dispersibility and prevents precipitation, while the nanoparticle form remains easy to produce through conventional synthesis methods.
4Reliability
If melanin nanoparticles are injected into the body, then contrast effect is provided, but rapid excretion occurs reducing retention time
Solution Approach 1:
The patent converts the typically harmful rapid clearance of nanoparticles by the reticuloendothelial system into a benefit by targeting melanoma cells that naturally accumulate melanin. The rapid uptake by melanoma cells transforms what would be rapid excretion into targeted accumulation at the disease site, providing both contrast effect and extended retention.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The melanin nanoparticles demonstrate excellent water dispersibility, long retention time in vivo, and non-toxicity, providing enhanced contrast effects and improved imaging capabilities compared to conventional agents.
Implementation Method 1
coordinate bonds between the melanin nanoparticles and paramagnetic ions
Implementation Method 2
modified the surface of the melanin nanoparticles with PEGs
Data Source
AI summary
The present invention relates to a contrast agent for nuclear magnetic resonance imaging, and more particularly, to a contrast agent for nuclear magnetic resonance imaging containing melanin nanoparticles having a uniform shape and size, thereby providing good dispersibility in water, no cell toxicity, and a long retention time in vivo.